Abiopharma

🔍 Foley Greg (Executive)

Company: Foxx Development Holdings Inc. (FOXX)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Sold 5,013 shares of Common Stock at $4.02 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,299.00 | transaction_form_type: 4
• Sold 2,584 shares of Common Stock at $3.98 per share (Direct)
  Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,715.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents unvested restricted shares from an initial grant of 24,312 restricted shares made on November 5, 2024. The remaining unvested restricted shares will continue to vest at a rate of 1/16th of the original grant amount on the quarterly anniversary date of the grant provided the reporting person remains in continuous service on each vesting date.